Precision Biosciences’ Programs Make a Stunning Return: Collaboration with Prevail Therapeutics Concludes
Precision BioSciences has regained control of three gene editing programs from Prevail Therapeutics, a subsidiary of Eli Lilly. The...
Jon Napitupulu
Medincell’s Partnership with AbbVie: Unlocking Next-Gen Injectable Therapies
Medincell has teamed up with AbbVie to develop and commercialize up to six innovative long-acting injectable (LAI) therapies. This...
Calidi Biotherapeutics IPO Raises $6.1 Million
Calidi Biotherapeutics, a biotechnology company focused on developing targeted immunotherapies, has priced its public offering for 15,197,500 shares of...
Biotech Asher Secures $55 Million Funding: Phase 1B Trials on the Horizon
Asher Biotherapeutics, a leader in developing targeted immunotherapies, has secured $55 million in Series C funding led by RA...
Volastra Therapeutics Announces First Patient Dosed in Phase Ib Clinical Trial of Sovilnesib
Volastra Therapeutics has advanced its clinical-stage KIF18A inhibitor, sovilnesib, into Phase Ib clinical trials. The trials will evaluate the...
Spikimm, Satt Conectus Join Forces for Innovative BK Virus Treatment
SpikImm, a biotech company established in 2021, has entered an exclusive agreement with SATT Conectus for the development of...
Marinus Pharmaceuticals Unveils Exciting Phase 3 RAISE Trial Update
Marinus Pharmaceuticals recently announced the continuation of its Phase 3 RAISE trial for intravenous (IV) ganaxolone in treating refractory...
Unlock the Latest in Cancer Treatment: Sanofi and Innate Pharma’s Sar443579/IPH6101 Breakthrough
Innate Pharma has announced the initiation of the Phase 2 dose expansion portion of a clinical trial sponsored by...
New Findings on Alzheimer’s Drug Daxxify Unveiled at Neurology Conference
Revance Therapeutics announced two poster presentations showcasing the efficacy and performance of DAXXIFY® for the treatment of cervical dystonia....
CND Life Sciences’ Skin Biopsy Tool: A Breakthrough for Parkinson’s Diagnosis
The Synuclein-One Study has successfully detected P-SYN in cutaneous nerve fibers of patients with dementia with Lewy bodies (DLB)...